Logo image of USWS

US WELL SERVICES INC (USWS) Stock Fundamental Analysis

NASDAQ:USWS - Nasdaq - US91274U3095 - Common Stock - Currency: USD

7.41  +0.19 (+2.63%)

After market: 7.24 -0.17 (-2.29%)

Fundamental Rating

1

Taking everything into account, USWS scores 1 out of 10 in our fundamental rating. USWS was compared to 59 industry peers in the Energy Equipment & Services industry. USWS may be in some trouble as it scores bad on both profitability and health. USWS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year USWS has reported negative net income.
USWS had a positive operating cash flow in the past year.
USWS Yearly Net Income VS EBIT VS OCF VS FCFUSWS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA -22.57%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USWS Yearly ROA, ROE, ROICUSWS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 200 400 600

1.3 Margins

Industry RankSector Rank
OM -25.29%
PM (TTM) -32.83%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USWS Yearly Profit, Operating, Gross MarginsUSWS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 -40 -60 -80

More info and screens

1

2. Health

2.1 Basic Checks

USWS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for USWS has been reduced compared to 1 year ago.
USWS has a worse debt/assets ratio than last year.
USWS Yearly Shares OutstandingUSWS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M
USWS Yearly Total Debt VS Total AssetsUSWS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.2 Solvency

USWS has an Altman-Z score of -1.85. This is a bad value and indicates that USWS is not financially healthy and even has some risk of bankruptcy.
USWS has a Debt/Equity ratio of -3.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -3.11
Debt/FCF N/A
Altman-Z -1.85
ROIC/WACCN/A
WACC4.37%
USWS Yearly LT Debt VS Equity VS FCFUSWS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M -100M 200M 300M

2.3 Liquidity

USWS has a Current Ratio of 0.72. This is a bad value and indicates that USWS is not financially healthy enough and could expect problems in meeting its short term obligations.
USWS has a Quick Ratio of 0.72. This is a bad value and indicates that USWS is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.63
USWS Yearly Current Assets VS Current LiabilitesUSWS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M

More info and screens

4

3. Growth

3.1 Past

USWS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.36%, which is quite impressive.
Looking at the last year, USWS shows a very negative growth in Revenue. The Revenue has decreased by -16.94% in the last year.
USWS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -27.19% yearly.
EPS 1Y (TTM)64.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.97%
Revenue 1Y (TTM)-16.94%
Revenue growth 3Y-27.19%
Revenue growth 5YN/A
Sales Q2Q%-12.73%

3.2 Future

USWS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.77% yearly.
Based on estimates for the next years, USWS will show a very strong growth in Revenue. The Revenue will grow by 20.38% on average per year.
EPS Next Y74.03%
EPS Next 2Y40.38%
EPS Next 3Y25%
EPS Next 5Y17.77%
Revenue Next Year-8.55%
Revenue Next 2Y18.93%
Revenue Next 3Y19.5%
Revenue Next 5Y20.38%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USWS Yearly Revenue VS EstimatesUSWS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
USWS Yearly EPS VS EstimatesUSWS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for USWS. In the last year negative earnings were reported.
Also next year USWS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USWS Price Earnings VS Forward Price EarningsUSWS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -14.36
USWS Per share dataUSWS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as USWS's earnings are expected to grow with 25.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.38%
EPS Next 3Y25%

More info and screens

0

5. Dividend

5.1 Amount

USWS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

US WELL SERVICES INC

NASDAQ:USWS (10/31/2022, 8:00:01 PM)

After market: 7.24 -0.17 (-2.29%)

7.41

+0.19 (+2.63%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)08-10 2022-08-10/amc
Earnings (Next)11-22 2022-11-22/bmo
Inst Owners0.04%
Inst Owner Change0%
Ins Owners102.51%
Ins Owner Change0%
Market Cap95.05M
Analysts45.71
Price Target7.04 (-4.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-38.58%
Min EPS beat(2)-55.34%
Max EPS beat(2)-21.81%
EPS beat(4)1
Avg EPS beat(4)-25.56%
Min EPS beat(4)-55.34%
Max EPS beat(4)14.26%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)10.96%
Min Revenue beat(2)2.39%
Max Revenue beat(2)19.53%
Revenue beat(4)3
Avg Revenue beat(4)2.47%
Min Revenue beat(4)-18.62%
Max Revenue beat(4)19.53%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF 7.51
P/B N/A
P/tB N/A
EV/EBITDA -14.36
EPS(TTM)-9.28
EYN/A
EPS(NY)-0.48
Fwd EYN/A
FCF(TTM)-5.35
FCFYN/A
OCF(TTM)0.99
OCFY13.31%
SpS16.01
BVpS-7.01
TBVpS-10.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -25.29%
PM (TTM) -32.83%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity -3.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 311.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.63
Altman-Z -1.85
F-Score4
WACC4.37%
ROIC/WACCN/A
Cap/Depr(3y)122.71%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.97%
EPS Next Y74.03%
EPS Next 2Y40.38%
EPS Next 3Y25%
EPS Next 5Y17.77%
Revenue 1Y (TTM)-16.94%
Revenue growth 3Y-27.19%
Revenue growth 5YN/A
Sales Q2Q%-12.73%
Revenue Next Year-8.55%
Revenue Next 2Y18.93%
Revenue Next 3Y19.5%
Revenue Next 5Y20.38%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-202.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.63%
OCF growth 3YN/A
OCF growth 5YN/A